Free tool
FAERS Monitor: Tarpeyo
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215935 or its brand name (Tarpeyo, Budesonide). Reports on generic versions are filed under their own applications.
Reports
46,292
Serious
32,716
71% of reports
Hospitalization
15,860
Death reported
3,173
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective5,153
- off label use4,835
- dyspnoea4,732
- asthma3,639
- fatigue3,216
- headache2,841
- diarrhoea2,581
- condition aggravated2,572
- nausea2,396
- cough2,338
- pneumonia2,300
- wheezing2,033
- pain1,978
- pyrexia1,959
- weight decreased1,833
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 138 |
| 2005 | 220 |
| 2006 | 195 |
| 2007 | 197 |
| 2008 | 282 |
| 2009 | 292 |
| 2010 | 320 |
| 2011 | 533 |
| 2012 | 736 |
| 2013 | 782 |
| 2014 | 978 |
| 2015 | 1,346 |
| 2016 | 1,591 |
| 2017 | 1,682 |
| 2018 | 2,259 |
| 2019 | 2,940 |
| 2020 | 3,524 |
| 2021 | 3,719 |
| 2022 | 4,585 |
| 2023 | 5,404 |
| 2024 | 5,618 |
| 2025 | 5,018 |
| 2026 | 3,933 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,007,867 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| wheezingSignal | 2,033 | 16.1 | 15.4 | 27,856 |
| asthmaSignal | 3,639 | 15.1 | 14.6 | 46,548 |
| condition aggravatedSignal | 2,572 | 3.9 | 3.7 | 5,500 |
| dyspnoeaSignal | 4,732 | 3.8 | 3.7 | 10,043 |
| coughSignal | 2,338 | 3.8 | 3.7 | 4,870 |
| pneumoniaSignal | 2,300 | 3.2 | 3.1 | 3,597 |
| weight decreasedSignal | 1,833 | 3.0 | 2.9 | 2,453 |
| pyrexiaSignal | 1,959 | 2.6 | 2.5 | 1,917 |
| off label useSignal | 4,835 | 2.5 | 2.5 | 4,586 |
| headacheSignal | 2,841 | 2.1 | 2.0 | 1,597 |
| fatigue | 3,216 | 1.9 | 1.8 | 1,370 |
| diarrhoea | 2,581 | 1.8 | 1.8 | 979 |
| drug ineffective | 5,153 | 1.8 | 1.7 | 1,869 |
| pain | 1,978 | 1.5 | 1.4 | 299 |
| nausea | 2,396 | 1.4 | 1.3 | 255 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.